Schonfeld Strategic Advisors LLC Eq Rx, Inc. Transaction History

Schonfeld Strategic Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.05 - $5.5 $366,464 - $983,196	178,763 Added 109.62%	341,845 $840,000
Q3 2022 Nov 14, 2022	BUY	$0.94 - $5.99 $153,297 - $976,861	163,082 New	163,082 $808,000
Q2 2022 Aug 15, 2022	SELL	$3.2 - $5.69 $1.42 Million - $2.52 Million	-442,777 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.8 - $7.39 $1.24 Million - $3.27 Million	442,777 New	442,777 $1.83 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.